Impact of dietary gut microbial metabolites on the epigenome

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 373, Issue 1748, 2018, Pages

  Gerhauser, Clarissa ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Diet; Epigenomics; Gut microbiota; Human health; Metabolism

Indexed keywords

BIOAVAILABILITY; CELL; DIGESTIVE SYSTEM; DNA; ENZYME; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC ANALYSIS; GENOME; METABOLISM; METABOLITE;

ANIMALIA;

DIET; GENETIC EPIGENESIS; HUMAN; INTESTINE FLORA; METAGENOME; PHYSIOLOGY;

DIET; EPIGENESIS, GENETIC; GASTROINTESTINAL MICROBIOME; HUMANS; METAGENOME;

EID: 85045954294     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2017.0359     Document Type: Review

References (97)

1. Flint HJ, Scott KP, Louis P, Duncan SH. 2012 The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 9, 577–589. (doi:10.1038/nrgastro.2012.156)
2. Graf D, Di Cagno R, Fak F, Flint HJ, Nyman M, Saarela M, Watzl B. 2015 Contribution of diet to the composition of the human gut microbiota. Microb. Ecol. Health Dis. 26, 26164. (doi:10.3402/mehd.v26.26164)
3. Qin J et al. 2010 A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65. (doi:10.1038/nature08821)
4. Arumugam M et al. 2011 Enterotypes of the human gut microbiome. Nature 473, 174–180. (doi:10. 1038/nature09944)
5. Wu GD et al. 2011 Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105–108. (doi:10.1126/science. 1208344)
6. Gorvitovskaia A, Holmes SP, Huse SM. 2016 Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle. Microbiome 4, 15. (doi:10.1186/s40168-016-0160-7)
7. Chatelier EL et al. 2013 Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541–546. (doi:10.1038/nature12506)
8. Cotillard A et al. 2013 Dietary intervention impact on gut microbial gene richness. Nature 500, 585–588. (doi:10.1038/nature12480)
9. Falony G et al. 2016 Population-level analysis of gut microbiome variation. Science 352, 560–564. (doi:10.1126/science.aad3503)
10. Zhernakova A et al. 2016 Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569. (doi:10.1126/science.aad3369)
11. Jones PA. 2012 Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484–492. (doi:10.1038/nrg3230)
12. Guil S, Esteller M. 2009 DNA methylomes, histone codes and miRNAs: tying it all together. Int. J. Biochem. Cell Biol. 41, 87–95. (doi:10.1016/j. biocel.2008.09.005)
13. Esteller M. 2007 Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8, 286–298. (doi:10.1038/nrg2005)
14. Berdasco M, Esteller M. 2010 Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev. Cell 19, 698–711. (doi:10.1016/j.devcel. 2010.10.005)
15. Kouzarides T. 2007 Chromatin modifications and their function. Cell 128, 693–705. (doi:10.1016/j. cell.2007.02.005)
16. Soshnev AA, Josefowicz SZ, Allis CD. 2016 Greater than the sum of parts: complexity of the dynamic epigenome. Mol. Cell 62, 681–694. (doi:10.1016/j. molcel.2016.05.004)
17. HGNC Database, HUGO Gene Nomenclature Committee. Gene family: lysine acetyltransferases (KAT). Hinxton: European Bioinformatics Institute. See http://www.genenames.org/cgi-bin/genefamilies/set/486 (accessed 25 August 2017).
18. Seto E, Yoshida M. 2014 Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb. Perspect. Biol. 6, a018713. (doi:10. 1101/cshperspect.a018713)
19. Upadhyay AK, Cheng X. 2011 Dynamics of histone lysine methylation: structures of methyl writers and erasers. Prog. Drug Res. 67, 107–124.
20. HGNC Database, HUGO Gene Nomenclature Committee. Gene family: lysine methyltransferases (KMT). Hinxton: European Bioinformatics Institute. See http://www.genenames.org/cgi-bin/genefamilies/set/487 (accessed 25 August 2017).
21. Allis CD et al. 2007 New nomenclature for chromatin-modifying enzymes. Cell 131, 633–636. (doi:10.1016/j.cell.2007.10.039)
22. HGNC Database, HUGO Gene Nomenclature Committee. Gene family: lysine demethylases (KDM). Hinxton: European Bioinformatics Institute. See http://www.genenames.org/cgi-bin/genefamilies/set/485 (accessed 25 August 2017).
23. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. 2009 Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11, 228–234. (doi:10.1038/ncb0309-228)
24. Heilmann K, Toth R, Bossmann C, Klimo K, Plass C, Gerhauser C. 2017 Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer. Oncogene 36, 6446–6461. (doi:10.1038/onc.2017.246)
25. Weiss M, Plass C, Gerhauser C. 2014 Role of lncRNAs in prostate cancer development and progression. Biol. Chem. 395, 1275–1290. (doi:10.1515/hsz-2014-0201)
26. Huang J, Plass C, Gerhauser C. 2011 Cancer chemoprevention by targeting the epigenome. Curr. Drug Targets 12, 1925–1956. (doi:10.2174/138945011798184155)
27. Gerhauser C. 2013 Cancer chemoprevention and nutriepigenetics: state of the art and future challenges. Top. Curr. Chem. 329, 73–132. (doi:10. 1007/128_2012_360)
28. Pudenz M, Roth K, Gerhauser C. 2014 Impact of soy isoflavones on the epigenome in cancer prevention. Nutrients 6, 4218–4272. (doi:10.3390/nu6104218)
29. Hullar MA, Fu BC. 2014 Diet, the gut microbiome, and epigenetics. Cancer J. 20, 170–175. (doi:10. 1097/PPO.0000000000000053)
30. Paul B, Barnes S, Demark-Wahnefried W, Morrow C, Salvador C, Skibola C, Tollefsbol TO. 2015 Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clin. Epigenetics 7, 112. (doi:10.1186/s13148-015-0144-7)
31. Mischke M, Plösch T. 2016 The gut microbiota and their metabolites: potential implications for the host epigenome. In Microbiota of the human body: implications in health and disease (ed. A Schwiertz), pp. 33–44. Cham, Switzerland: Springer International Publishing.
32. Lamprecht SA, Lipkin M. 2003 Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat. Rev. Cancer 3, 601–614. (doi:10.1038/nrc1144)
33. Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, Miller BJ, Henning SM, Swendseid ME. 1998 Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J. Nutr. 128, 1204–1212. (doi:10.1093/jn/128.7.1204)
34. Rossi M, Amaretti A, Raimondi S. 2011 Folate production by probiotic bacteria. Nutrients 3, 118–134. (doi:10.3390/nu3010118)
35. Gerhauser C. 2012 Cancer cell metabolism, epigenetics and the potential influence of dietary components: a perspective. Biomed. Res. India 23, 69–89.
36. Possemiers S, Bolca S, Verstraete W, Heyerick A. 2011 The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals. Fitoterapia 82, 53–66. (doi:10.1016/j.fitote.2010.07.012)
37. Jenner AM, Rafter J, Halliwell B. 2005 Human fecal water content of phenolics: the extent of colonic exposure to aromatic compounds. Free Radic. Biol. Med. 38, 763–772. (doi:10.1016/j.freeradbiomed. 2004.11.020)
38. Braune A, Blaut M. 2016 Bacterial species involved in the conversion of dietary flavonoids in the human gut. Gut Microbes 7, 216–234. (doi:10. 1080/19490976.2016.1158395)
39. Paluszczak J, Krajka-Kuzniak V, Baer-Dubowska W. 2010 The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol. Lett. 192, 119–125. (doi:10.1016/j.toxlet.2009.10.010)
40. Waldecker M, Kautenburger T, Daumann H, Busch C, Schrenk D. 2008 Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J. Nutr. Biochem. 19, 587–593. (doi:10.1016/j. jnutbio.2007.08.002)
41. Waldecker M, Kautenburger T, Daumann H, Veeriah S, Will F, Dietrich H, Pool-Zobel BL, Schrenk D. 2008 Histone-deacetylase inhibition and butyrate formation: fecal slurry incubations with apple pectin and apple juice extracts. Nutrition 24, 366–374. (doi:10.1016/j.nut.2007.12.013)
42. Espin JC, Larrosa M, Garcia-Conesa MT, Tomas- Barberan F. 2013 Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far. Evid. Based Complement. Alternat. Med. 2013, 270418. (doi:10. 1155/2013/270418)
43. Tomas-Barberan FA, Gonzalez-Sarrias A, Garcia- Villalba R, Nunez-Sanchez MA, Selma MV, Garcia-Conesa MT, Espin JC. 2017 Urolithins, the rescue of ‘old’ metabolites to understand a ‘new’ concept: metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status. Mol. Nutr. Food Res. 61, 1500901. (doi:10. 1002/mnfr.201500901)
44. Wen XY, Wu SY, Li ZQ, Liu ZQ, Zhang JJ, Wang GF, Jiang ZH, Wu SG. 2009 Ellagitannin (BJA3121), an anti-proliferative natural polyphenol compound, can regulate the expression of miRNAs in HepG2 cancer cells. Phytother. Res. 23, 778–784. (doi:10.1002/ptr.2616)
45. Gonzalez-Sarrias A, Nunez-Sanchez MA, Tome- Carneiro J, Tomas-Barberan FA, Garcia-Conesa MT, Espin JC. 2016 Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key-associated molecular hallmarks: microRNA cell specific induction of CDKN1A (p21) as a common mechanism involved. Mol. Nutr. Food Res. 60, 701–716. (doi:10.1002/mnfr.201500780)
46. Kiss AK, Granica S, Stolarczyk M, Melzig MF. 2012 Epigenetic modulation of mechanisms involved in inflammation: influence of selected polyphenolic substances on histone acetylation state. Food Chem. 131, 1015–1020. (doi:10.1016/j.foodchem. 2011.09.109)
47. Myzak MC, Karplus PA, Chung FL, Dashwood RH. 2004 A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res. 64, 5767–5774. (doi:10.1158/0008-5472.CAN-04-1326)
48. Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. 2012 The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 48, 612–626. (doi:10.1016/j.molcel. 2012.08.033)
49. Dimri M, Bommi P, Sahasrabuddhe AA, Khandekar JD, Dimri GP. 2010 Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis 31, 489–495. (doi:10.1093/carcin/bgp305)
50. Morey Kinney SR, Zhang W, Pascual M, Greally JM, Gillard BM, Karasik E, Foster BA, Karpf AR. 2009 Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate. Cancer Prev. Res. (Philadelphia) 2, 1065–1075. (doi:10. 1158/1940-6207.CAPR-09-0010)
51. Wang LS et al. 2011 Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study. Clin. Cancer Res. 17, 598–610. (doi:10.1158/1078-0432.CCR-10-1260)
52. Wang LS et al. 2014 A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis. Cancer Prev. Res. 7, 666–674. (doi:10.1158/1940-6207.CAPR-14-0052)
53. Min/+ mice: relation to metabolite profiles. Carcinogenesis 36, 1245–1253. (doi:10.1093/carcin/bgv117)
54. Pan P, Skaer CW, Wang HT, Kreiser MA, Stirdivant SM, Oshima K, Huang YW, Young MR, Wang LS. 2017 Systemic metabolite changes in wild-type C57BL/6 mice fed black raspberries. Nutr. Cancer 69, 299–306. (doi:10.1080/01635581.2017.1263748)
55. Pan P, Lam V, Salzman N, Huang YW, Yu J, Zhang J, Wang LS. 2017 Black raspberries and their anthocyanin and fiber fractions alter the composition and diversity of gut microbiota in F-344 rats. Nutr. Cancer 69, 943–951. (doi:10. 1080/01635581.2017.1340491)
56. Nunez-Sanchez MA et al. 2015 MicroRNAs expression in normal and malignant colon tissues as biomarkers of colorectal cancer and in response to pomegranate extracts consumption: critical issues to discern between modulatory effects and potential artefacts. Mol. Nutr. Food Res. 59, 1973–1986. (doi:10.1002/mnfr.201500357)
57. Clarke JD, Riedl K, Bella D, Schwartz SJ, Stevens JF, Ho E. 2011 Comparison of isothiocyanate metabolite levels and histone deacetylase activity in human subjects consuming broccoli sprouts or broccoli supplement. J. Agric. Food Chem. 59, 10 955– 10 963. (doi:10.1021/jf202887c)
58. Dashwood RH, Ho E. 2007 Dietary histone deacetylase inhibitors: from cells to mice to man. Semin. Cancer Biol. 17, 363–369. (doi:10.1016/j. semcancer.2007.04.001)
59. min mice. FASEB J. 20, 506–508. (doi:10.1096/fj.05-4785fje)
60. Donohoe DR et al. 2014 A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov. 4, 1387–1397. (doi:10.1158/2159-8290.CD-14-0501)
61. Wall R, Ross RP, Shanahan F, O’Mahony L, Kiely B, Quigley E, Dinan TG, Fitzgerald G, Stanton C. 2010 Impact of administered Bifidobacterium on murine host fatty acid composition. Lipids 45, 429–436. (doi:10.1007/s11745-010-3410-7)
62. Davidson LA, Wang N, Shah MS, Lupton JR, Ivanov I, Chapkin RS. 2009 n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 30, 2077–2084. (doi:10.1093/carcin/bgp245)
63. Hill MJ. 1997 Intestinal flora and endogenous vitamin synthesis. Eur. J. Cancer Prev. 6(Suppl. 1), S43–S45. (doi:10.1097/00008469-199703001-00009)
64. Burgio G, Onorati MC, Corona DF. 2010 Chromatin remodeling regulation by small molecules and metabolites. Biochim. Biophys. Acta 1799, 671–680. (doi:10.1016/j.bbagrm.2010.05.007)
65. Gerhauser C. 2014 Epigenetics, (poly) phenolics and cancer prevention. In Recent advances in polyphenol research, vol. 4 (eds A Romani, S Quideau), pp. 143–207. Hoboken, NJ: John Wiley & Sons, Ltd.
66. Virk-Baker MK, Barnes S, Krontiras H, Nagy TR. 2014 S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy. Nutr. Res. 34, 116–125. (doi:10.1016/j.nutres.2013.12.002)
67. Steiner C, Arnould S, Scalbert A, Manach C. 2008 Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics. Br. J. Nutr. 99E(Suppl. 1), ES78–ES108.
68. Setchell KD, Clerici C. 2010 Equol: history, chemistry, and formation. J. Nutr. 140, 1355S–1362S. (doi:10. 3945/jn.109.119776)
69. Lee WJ, Shim JY, Zhu BT. 2005 Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. 68, 1018–1030. (doi:10.1124/mol.104.008367)
70. Stoner GD, Wang LS, Zikri N, Chen T, Hecht SS, Huang C, Sardo C, Lechner JF. 2007 Cancer prevention with freeze-dried berries and berry components. Semin. Cancer Biol. 17, 403–410. (doi:10.1016/j.semcancer.2007.05.001)
71. Ismail T, Calcabrini C, Diaz AR, Fimognari C, Turrini E, Catanzaro E, Akhtar S, Sestili P. 2016 Ellagitannins in cancer chemoprevention and therapy. Toxins 8, 151. (doi:10.3390/toxins8050151)
72. Tomas-Barberan FA, Selma MV, Espin JC. 2016 Interactions of gut microbiota with dietary polyphenols and consequences to human health. Curr. Opin. Clin. Nutr. Metab. Care 19, 471–476. (doi:10.1097/MCO.0000000000000314)
73. Tomas-Barberan FA, Garcia-Villalba R, Gonzalez- Sarrias A, Selma MV, Espin JC 2014 Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. J. Agric. Food Chem. 62, 6535– 6538. (doi:10.1021/jf5024615)
74. Gonzalez-Sarrias A, Garcia-Villalba R, Romo-Vaquero M, Alasalvar C, Orem A, Zafrilla P, Tomas-Barberan FA, Selma MV, Espin JC. 2016 Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: a randomised clinical trial. Mol. Nutr. Food Res. 61, 1600830. (doi:10.1002/mnfr.201600830)
75. Zhang W, Chen JH, Aguilera-Barrantes I, Shiau CW, Sheng X, Wang LS, Stoner GD, Huang YW. 2016 Urolithin A suppresses the proliferation of endometrial cancer cells by mediating estrogen receptorα-dependent gene expression. Mol. Nutr. Food Res. 60, 2387–2395. (doi:10.1002/mnfr.201600048)
76. Nunez-Sanchez MA et al. 2017 Gene expression changes in colon tissues from colorectal cancer patients following the intake of an ellagitannin-containing pomegranate extract: a randomized clinical trial. J. Nutr. Biochem. 42, 126–133. (doi:10.1016/j.jnutbio.2017.01.014)
77. Verkerk R et al. 2009 Glucosinolates in Brassica vegetables: the influence of the food supply chain on intake, bioavailability and human health. Mol. Nutr. Food Res. 53(Suppl. 2), S219. (doi:10.1002/mnfr.200800065)
78. Dufour V, Stahl M, Baysse C. 2015 The antibacterial properties of isothiocyanates. Microbiology 161, 229–243. (doi:10.1099/mic.0.082362-0)
79. Thomson CA, Dickinson S, Bowden GT. 2010 Cruciferous vegetables, isothiocyanates, indoles, and cancer prevention. In Bioactive compounds and cancer (eds JA Milner, DF Romagnolo), pp. 535–566. Totowa, NJ: Humana Press.
80. Houghton CA, Fassett RG, Coombes JS. 2013 Sulforaphane: translational research from laboratory bench to clinic. Nutr. Rev. 71, 709–726. (doi:10. 1111/nure.12060)
81. Getahun SM, Chung FL. 1999 Conversion of glucosinolates to isothiocyanates in humans after ingestion of cooked watercress. Cancer Epidemiol. Biomarkers Prev. 8, 447–451.
82. Conaway CC, Getahun SM, Liebes LL, Pusateri DJ, Topham DK, Botero-Omary M, Chung FL. 2000 Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr. Cancer 38, 168–178. (doi:10.1207/S15327914NC382_5)
83. Rouzaud G, Young SA, Duncan AJ. 2004 Hydrolysis of glucosinolates to isothiocyanates after ingestion of raw or microwaved cabbage by human volunteers. Cancer Epidemiol. Biomarkers Prev. 13, 125–131. (doi:10.1158/1055-9965.EPI-085-3)
84. Li F, Hullar MA, Beresford SA, Lampe JW. 2011 Variation of glucoraphanin metabolism in vivo and ex vivo by human gut bacteria. Br. J. Nutr. 106, 408–416. (doi:10.1017/S0007114511000274)
85. Tian S, Liu X, Lei P, Zhang X, Shan Y. 2017 Microbiota: a mediator to transform glucosinolate precursors in cruciferous vegetables to the active isothiocyanates. J. Sci. Food Agric. 98, 1255–1260. (doi:10.1002/jsfa.8654)
86. Li F, Hullar MA, Schwarz Y, Lampe JW. 2009 Human gut bacterial communities are altered by addition of cruciferous vegetables to a controlled fruit- and vegetable-free diet. J. Nutr. 139, 1685–1691. (doi:10.3945/jn.109.108191)
87. Gerhauser C. 2013 Epigenetic impact of dietary isothiocyanates in cancer chemoprevention. Curr. Opin. Clin. Nutr. Metab. Care 16, 405–410. (doi:10. 1097/MCO.0b013e328362014e)
88. Watson GW, Beaver LM, Williams DE, Dashwood RH, Ho E. 2013 Phytochemicals from cruciferous vegetables, epigenetics, and prostate cancer prevention. AAPS J. 15, 951–961. (doi:10.1208/s12248-013-9504-4)
89. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. 2013 The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54, 2325–2340. (doi:10.1194/jlr.R036012)
90. Bultman SJ. 2017 Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer. Mol. Nutr. Food Res. 61, 1500902. (doi:10.1002/mnfr.201500902)
91. Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, Van Immerseel F. 2010 From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr. Res. Rev. 23, 366–384. (doi:10. 1017/S0954422410000247)
92. O’Keefe SJ. 2016 Diet, microorganisms and their metabolites, and colon cancer. Nat. Rev. Gastroenterol. Hepatol. 13, 691–706. (doi:10.1038/nrgastro.2016.165)
93. Davie JR. 2003 Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133, 2485S–2493S. (doi:10.1093/jn/133.7.2485S)
94. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. 2008 Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27, 104–119. (doi:10.1111/j.1365-2036.2007. 03562.x)
95. Berquin IM, Edwards IJ, Chen YQ. 2008 Multitargeted therapy of cancer by omega-3 fatty acids. Cancer Lett. 269, 363–377. (doi:10.1016/j.canlet. 2008.03.044)
96. Marventano S, Kolacz P, Castellano S, Galvano F, Buscemi S, Mistretta A, Grosso G. 2015 A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter? Int. J. Food Sci. Nutr. 66, 611–622. (doi:10.3109/09637486.2015.1077790)
97. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. 2009 The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 1, 6ra14. (doi:10.1126/scitranslmed.3000322)